Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy
- 17 December 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 312 (23), 2521-2530
- https://doi.org/10.1001/jama.2014.15704
Abstract
Research from JAMA — Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy — A Randomized Clinical TrialKeywords
This publication has 28 references indexed in Scilit:
- A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?Breast Cancer Research and Treatment, 2011
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'AdulteBlood, 2010
- High prevalence of hepatitis B virus infection in patients with B‐cell non‐Hodgkin's lymphoma in KoreaJournal of Medical Virology, 2008
- A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trialHepatology, 2007
- High incidence of hepatitis B virus infection in B‐cell subtype non‐Hodgkin lymphoma compared with other cancersCancer, 2007
- Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapyBritish Journal of Cancer, 2004
- Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic ChemotherapyJournal of Clinical Oncology, 2004
- Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapyGastroenterology, 2003
- Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective studyJournal of Medical Virology, 2003
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002